These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24782132)

  • 1. Screening of the residual normal ovarian tissue adjacent to orthotopic epithelial ovarian carcinomas in nude mice.
    Zhu GH; Wang ST; Yao MZ; Cai JH; Chen CY; Yang ZX; Hong L; Yang SY
    Genet Mol Res; 2014 Apr; 13(2):2978-86. PubMed ID: 24782132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety assessment of ovarian cryopreservation and transplantation in nude mice bearing human epithelial ovarian cancer.
    Zhu GH; Wang ST; Yang ZX; Cai JH; Chen CY; Yao MZ; Hong L; He GL; Yang SY
    Asian Pac J Cancer Prev; 2012; 13(9):4669-75. PubMed ID: 23167400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 4. [Expression of Jagged1 mRNA in human epithelial ovarian carcinoma tissues and effect of RNA interference of Jagged1 on growth of xenograft in nude mice].
    Liu GY; Gao ZH; Li L; Song TT; Sheng XG
    Zhonghua Fu Chan Ke Za Zhi; 2016 Jun; 51(6):448-53. PubMed ID: 27356481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
    Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
    Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two kinds of orthotopic xenograft models for human ovarian cancer.
    Zhu G; Hong L; Wang S; Junhong Cai ; Yang Z; Yao M
    Eur J Gynaecol Oncol; 2014; 35(6):724-7. PubMed ID: 25556281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of circadian gene Period2 expression in epithelial ovarian cancer and the effect of gene overexpression on growth of ovarian cancer xenografts in nude mice].
    Wang Z; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Jun; 50(6):446-51. PubMed ID: 26311553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD40 ligands sensitize the epithelial ovarian cancer cells to cisplatin treatment.
    Qin L; Qiu H; Zhang M; Zhang F; Yang H; Yang L; Jia L; Qin K; Jia L; Dou X; Cheng L; Sang M; Zhang C; Shan B; Zhang Z
    Biomed Pharmacother; 2016 Apr; 79():166-75. PubMed ID: 27044825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
    Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
    Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
    Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
    PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
    Xia B; Yang S; Liu T; Lou G
    Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
    Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
    Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting HSF1 leads to an antitumor effect in human epithelial ovarian cancer.
    Chen YF; Wang SY; Yang YH; Zheng J; Liu T; Wang L
    Int J Mol Med; 2017 Jun; 39(6):1564-1570. PubMed ID: 28487934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer.
    Guo Y; Fu P; Zhu H; Reed E; Remick SC; Petros W; Mueller MD; Yu JJ
    Oncol Rep; 2012 Jan; 27(1):286-92. PubMed ID: 21971700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer.
    Gao Y; Foster R; Yang X; Feng Y; Shen JK; Mankin HJ; Hornicek FJ; Amiji MM; Duan Z
    Oncotarget; 2015 Apr; 6(11):9313-26. PubMed ID: 25823654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo.
    Zhang X; Liu P; Zhang B; Mao H; Shen L; Ma Y
    Int J Mol Med; 2013 Sep; 32(3):623-8. PubMed ID: 23828376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
    Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
    Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of SENP3/SMT3IP1 promotes epithelial ovarian cancer progression and forecasts poor prognosis.
    Cheng J; Su M; Jin Y; Xi Q; Deng Y; Chen J; Wang W; Chen Y; Chen L; Shi N; Mao G
    Tumour Biol; 2017 Mar; 39(3):1010428317694543. PubMed ID: 28351334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-137 suppresses tumor growth in epithelial ovarian cancer in vitro and in vivo.
    Zhang L; Li Z; Gai F; Wang Y
    Mol Med Rep; 2015 Aug; 12(2):3107-14. PubMed ID: 25955305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.